Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Mechanisms of obesity-induced gastrointestinal neoplasia.

Alemán JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR.

Gastroenterology. 2014 Feb;146(2):357-373. doi: 10.1053/j.gastro.2013.11.051. Epub 2013 Dec 6. Review.

2.

Nutrition in the prevention of gastrointestinal cancer.

van den Brandt PA, Goldbohm RA.

Best Pract Res Clin Gastroenterol. 2006;20(3):589-603. Review.

PMID:
16782531
3.

Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.

Kashyap MK.

Tumour Biol. 2015 Nov;36(11):8247-57. doi: 10.1007/s13277-015-3972-3. Epub 2015 Sep 14. Review.

PMID:
26369544
4.

Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.

Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird NC, Wu AH, Corley DA, Romero Y, Chanock SJ, Chow WH, Casson AG, Levine DM, Zhang R, Ek WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC.

J Natl Cancer Inst. 2014 Sep 30;106(11). pii: dju252. doi: 10.1093/jnci/dju252. Print 2014 Nov.

5.

Obesity-associated digestive cancers: A review of mechanisms and interventions.

Zheng J, Zhao M, Li J, Lou G, Yuan Y, Bu S, Xi Y.

Tumour Biol. 2017 Mar;39(3):1010428317695020. doi: 10.1177/1010428317695020. Review.

PMID:
28351315
6.

Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.

Siahpush SH, Vaughan TL, Lampe JN, Freeman R, Lewis S, Odze RD, Blount PL, Ayub K, Rabinovitch PS, Reid BJ, Chen C.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2387-95.

7.

Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.

Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, Hung MC.

Cancer Res. 2008 Apr 15;68(8):2632-40. doi: 10.1158/0008-5472.CAN-07-5460.

8.

Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.

Khan S, Shukla S, Sinha S, Meeran SM.

Cytokine Growth Factor Rev. 2013 Dec;24(6):503-13. doi: 10.1016/j.cytogfr.2013.10.001. Epub 2013 Oct 21. Review.

PMID:
24210902
9.

IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity.

Doyle SL, Donohoe CL, Finn SP, Howard JM, Lithander FE, Reynolds JV, Pidgeon GP, Lysaght J.

Am J Gastroenterol. 2012 Feb;107(2):196-204. doi: 10.1038/ajg.2011.417. Epub 2011 Dec 6.

PMID:
22146489
10.

Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.

Kwak EL, Jankowski J, Thayer SP, Lauwers GY, Brannigan BW, Harris PL, Okimoto RA, Haserlat SM, Driscoll DR, Ferry D, Muir B, Settleman J, Fuchs CS, Kulke MH, Ryan DP, Clark JW, Sgroi DC, Haber DA, Bell DW.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4283-7.

11.

The esophagitis to adenocarcinoma sequence; the role of inflammation.

Kavanagh ME, O'Sullivan KE, O'Hanlon C, O'Sullivan JN, Lysaght J, Reynolds JV.

Cancer Lett. 2014 Apr 10;345(2):182-9. doi: 10.1016/j.canlet.2013.08.017. Epub 2013 Aug 27. Review.

PMID:
23994342
12.

Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues.

Zou T, Fleisher AS, Kong D, Yin J, Souza RF, Wang S, Smolinski KN, Abraham JM, Meltzer SJ.

Cancer Res. 1998 Nov 1;58(21):4802-4.

13.

Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.

Adachi Y, Li R, Yamamoto H, Min Y, Piao W, Wang Y, Imsumran A, Li H, Arimura Y, Lee CT, Imai K, Carbone DP, Shinomura Y.

Carcinogenesis. 2009 Aug;30(8):1305-13. doi: 10.1093/carcin/bgp134. Epub 2009 Jun 3.

PMID:
19493905
14.

Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract.

Feakins RM.

Histopathology. 2016 Apr;68(5):630-40. doi: 10.1111/his.12907. Epub 2016 Jan 19. Review.

PMID:
26599607
15.

Link of obesity and gastrointestinal cancer: crossroad of inflammation and oxidative stress.

Yang XD, Jiang S, Wang G, Zhang R, Zhang J, Zhu JS.

J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):755-60. Review.

PMID:
26753635
16.

Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective.

Feng HY, Chen YC.

World J Gastroenterol. 2016 Sep 7;22(33):7463-77. doi: 10.3748/wjg.v22.i33.7463. Review.

17.

The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma.

Adachi Y, Ohashi H, Imsumran A, Yamamoto H, Matsunaga Y, Taniguchi H, Nosho K, Suzuki H, Sasaki Y, Arimura Y, Carbone DP, Imai K, Shinomura Y.

Tumour Biol. 2014 Feb;35(2):973-85. doi: 10.1007/s13277-013-1131-2. Epub 2013 Sep 13.

PMID:
24026884
18.

Mechanisms behind the link between obesity and gastrointestinal cancers.

Tilg H, Moschen AR.

Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):599-610. doi: 10.1016/j.bpg.2014.07.006. Epub 2014 Jul 11. Review.

PMID:
25194178
19.
20.

A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.

MacDonald K, Porter GA, Guernsey DL, Zhao R, Casson AG.

Cancer Epidemiol. 2009 Jul;33(1):37-40. doi: 10.1016/j.canep.2009.04.014. Epub 2009 May 28.

PMID:
19679045

Supplemental Content

Support Center